Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity

Cytometry

Volumn 27, Issue 1, 1997, Pages 54-64

  Vaisman, Alexandra ^a   Varchenko, Maria ^a   Said, Isil ^a   Chaney, Stephen G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cell cycle perturbations; cisplatin; DNA damage; drug resistance

Indexed keywords

CISPLATIN;

ARTICLE; CELL CYCLE PHASE; CELL LINE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

CARCINOMA; CELL CYCLE; CISPLATIN; DNA ADDUCTS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031038223     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970101)27:1<54::AID-CYTO7>3.0.CO;2-L     Document Type: Article

References (31)

1. Anthoney DA, Mcilwrath AJ, Gallagher WM, Edlin ARM, Brown R: Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res 56:1374-1381 (1996).
2. Andrews PA, Murphy MP, Howell SB: Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res 45:6250-6253 (1985).
3. Bergerat JP, Barlogie B, Gohde W, Johnston DA, Drewinko B: In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II). Cancer Res 39:4356-4363 (1979).
4. Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B, Kaye SB: Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer 55:678-684 (1993).
5. Demarcq C, Bastian G, Remvikos Y: BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells. Cytometry 13:416-422 (1992).
6. Demarcq C, Bunch RT, Creswell D, Eastman A: The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. Cell Growth and Differentiation 5:983-993 (1994).
7. Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ Jr, O'Connor PM: Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55:1649-1654 (1995).
8. Fujikane T, Shimizu T, Tsuji T, Ishida S, Ohsaki Y, Onodera S: Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells. Cytometry 10:788-795 (1989).
9. Gibbons GR, Kaufmann WK, Chancy SG: Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells. Carcinogenesis 12:2253-2257 (1991).
10. Jackel M, Kopf-Maier P: Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas. Cancer Chemother Pharmacol 27:464-471 (1991).
11. Just G, Holler E: Platinum incorporation and differential effects of cis-and trans-diamminedichloroplatinum(II) on the growth of mouse leukemia P388/D1. Cancer Res 49:7072-7077 (1989).
12. Kanno S, Hyodo M, Suzuki K, Ohkido M: Effect of DNA-damaging agents on DNA replication and cell-cycle progression of cultured mouse mammary carcinoma cells. Jpn J Cancer Res 76:289-296 (1985).
13. Korf-Maier P, Wagner W, Liss E: Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro. J Cancer Res Clin Oncol 106:44-52 (1983).
14. Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, Chancy SG: Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res 54:3500-3505 (1994).
15. Mares V, Giordano PA, Mazzini G, Lisa V, Pellicciari C, Scherini E, Bottiroli G, Drobnik J: Influence of cis-dichlorodiammineplatinum on glioma cell morphology and cell cycle kinetics in tissue culture. Histochemical J 19:187-194 (1987).
16. Masuda H, Tanaka T, Matsuda H, Kusaba I: Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res 50:1863-1866 (1990).
17. Moran RE, Straus MJ: Effects of pulse and continuous intravenous infusion of cis-diamminedichloroplatinum on L1210 leukemia in vivo. Cancer Res 41:4993-4996 (1981).
18. Nishio K, Fujiwara Y, Miyahara Y, Takeda Y, Ohira T, Kubota N, Ohta S, Funayama Y, Ogasawara H, Ohata M, Saijo N: Cis-diamminedichloroplatinum(II) inhibits p34(cdc2) protein kinase in human lung-cancer cells. Int J Cancer 55:616-622 (1993).
19. O'Connor PM, Ferris DK, Hoffmann I, Jackman J, Draetta G, Kohn KW: Role of the cdc25C phosphatase in G(2) arrest induced by nitrogen mustard. Proc Natl Acad Sci USA 91:9480-9484 (1994).
20. Ormerod MG, Orr RM, Peacock JH: The role of apoptosis in cell killing by cisplatin - a flow cytometric study. Br J Cancer 69:93-100 (1994).
21. Perras JP, Ramos R, Sevin BU: Demonstration of an S phase population of cells without DNA synthesis generated by CP and pentoxifylline. Cytometry 14:441-448 (1993).
22. Schaefer DI, Livanos EM, White AE, Tlsty TD: Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts. Cancer Res 53:4946-4951 (1993).
23. Schmidt W, Chaney SG: Role of carrier ligand in platinum resistance of human carcinoma cell lines. Cancer Res 53:799-805 (1993).
24. Schwabe HW, Adolphs HD, Hartlapp J: Flow-cytophotometric studies on urine sediments of patients treated with anti-cancer-drugs. Urological Res 11:159-162 (1983).
25. Sorenson CM, Eastman A: Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res 48:6703-6707 (1988).
26. Sorenson CM, Eastman A: Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA doublestrand breaks. Cancer Res 48:4484-4488 (1988).
27. Takahashi K, Ebihara K, Honda Y, Nishikawa K, Kita M, Oomura M, Shibasaki C: Antitumor activity of cis-dichlorodiammineplatinum(II) and its effect on cell cycle progression. Gan to Kagaku Ryoho [Japanese Journal of Cancer & Chemotherapy] 9:624-631 (1982).
28. Thiebaut F, Enns R, Howell SB: Cisplatin sensitivity correlates with its ability to cause cell cycle arrest via a wee1 kinase-dependent pathway in Schizosaccharomyces pombe. J Cell Physiol 159:506-514 (1994).
29. Vaisman A, Chancy SG: Induction of UV-damage recognition protein by cisplatin treatment. Biochemistry 34:105-14 (1995).
30. Wennerberg J, Alm P, Biorklund A, Killander D, Langstrom E, Trope C: Cell cycle perturbations in heterotransplanted squamous-cell carcinoma of the head and neck after mitomycin C and cisplatin treatment. Int J Cancer 33:213-222 (1984).
31. Yokomori K, Tsuchida Y, Saito S, Yamamoto H, Takakura K, Nomura K: Synchronization effect of cis-dichlorodiammineplatinum on a human neuroblastoma in vitro and in nude mice. Gann 74:902-910 (1983).